Probiotics have long been known
to aid in common digestive complaints including lactose intolerance
and diarrhea. They also help to relieve diarrhea, constipation,
bloating, and cramping caused by IBS, Crohn’s disease and
ulcerative colitis. In recent years other benefits of probiotics
have included boosting the immune system and overall health, reducing
yeast infections, improving calcium and nutrient absorption, and
providing relief from psoriasis, arthritis, and even asthma.
Despite these wonderful health benefits, one thing has remained
a constant problem: delivering the probiotic organisms to the lower
digestive tract alive and in tact. If a probiotic supplement does
not survive on the shelf for very long (and/or must be refrigerated
to maintain potency), it is difficult to say how many viable organisms
are present in the supplement when you actually take it. Also, if
the probiotics do not survive the passage through the acidic environment
of your stomach, they will not reach the lower digestive tract where
they exert their health benefits. Our research team of chemists
and pharmacists at GetRight™ Probiotics knew that this was
critical to the success of our product so we searched diligently
to find the right technology to guarantee that our probiotics survive
their journey from the manufacturer to you in addition to the journey
through your stomach to the lower digestive tract.
The patented BIO-tract® technology does just that. Nutraceutix,
Inc. (Redmond, WA) is the pioneer in the technological advancement
of delivering active organisms to the lower digestive tract. Their
development of the BIO-tract® technology has been integral to
the creation of GetRight™ Probiotics. This technology allows
GetRight™ Probiotics to be delivered alive and in tact directly
to the lower digestive tract where they exert their beneficial effects.
No matter how many CFU’s (colony forming units) a product
promises, unless they are delivered alive and intact and in sufficient
quantities, they may only provide marginal health benefits or no
benefits at all. GetRight™ Probiotics is proud to utilize
BIO-tract® technology, and our researchers are confident that
it is the best probiotics supplement on the market.
† These statements have not been evaluated
by the Food and Drug Administration. This product is not intended
to diagnose, treat, cure or prevent any disease.
The purpose of this probiotic product is to alleviate gastrointestinal
discomfort caused by an abnormal gut flora (the billions of bacteria
found in the intestines and bowel that help regulate many processes
in the body, most notably digestion) by delivering high numbers
of organisms to the lower gastrointestinal tract. It is targeted
to help with conditions such as (but not limited to):
Lactose Intolerance
Diarrhea (antibiotic-induced and traveler’s)
Constipation
Irritable Bowel Syndrome
Irritable Bowel Disease
Ulcerative Colitis
Pouchitis
There are thousands of research articles supporting the health benefits
of probiotics. Below are a few references that pertain to the actual
types of organisms in GetRight™ Probiotics.
Nutr Res 2006; 26 (9): 454-459. “Daily Ingestion of a Nutritional
Probiotic Supplement Enhances Innate Immune Function in Healthy
Adults”
This article shows an increase in key immune function parameters
with daily use of a probiotic supplement manufactured by Nutraceutix,
Inc. employing the patented BIO-tract ® technology. This supports
the claim that this dosage form delivers the organisms to where
they are needed to confer their health benefits. Available online
at www.sciencedirect.com.
Nutr Res 1995; 15: 1287-1295. “Lactase
Activity of Bifidobacterium bifidum”
This article investigates the lactase activity of this probiotic
organism. Lactase is the enzyme that breaks down lactose, the main
sugar in many dairy products. Many probiotics possess high lactase
activity helping those with lactose intolerance digest such foods.
Available online at www.sciencedirect.com.
N Engl J Med 1995; 333 (20): 1360-1361.
“Lactobacilli to Prevent Traveler’s Diarrhea?”
This article reports the efficacy of using probiotics to help prevent
this common disruption in travelers. The article is available online
at www.content.nejm.org.
Gut 1994; 35: 658-664. “Pouchitis:
result of microbial imbalance?”
This article explores the concept that a healthy gut flora can prevent
certain inflammatory diseases such as pouchitis. It is available
at www.gut.bmj.com.
J Dairy Sci 1995; 78: 1657-1664. “Effects of Milks Inoculated
with Lactobacillus acidophilus or a Yogurt Starter Culture in Lactose-Maldigesting
Children”
This article supports the increased metabolism of lactose-containing
foods with consumption of Lactobacillus acidophilus. Full text available
online at www.jds.fass.org.
Agric Biol Chem 1986; 50 (9): 2275-2286.
“p-Nitrophenyl Glycoside-hydrolyzing Activities in Bifidobacteria
and Characterization of ß-D-Galactosidase of Bifidobacterium
longum 401”
This article investigates enzyme activities involved in breaking
down several other dietary sugars. Some people with lactose intolerance
may lack certain enzymes that break down important sugars other
than lactose, and this article supports the gastrointestinal relief
subjects feel with probiotic supplementation. Text at www.journalarchive.jst.go.jp/english/jnltoc_en.php?cdjournal=bbb1961&cdvol=49&noissue=9.
Am J Clin Nutr 2001; 73(suppl):430S-436S.
“Protection from gastrointestinal diseases with the use of
probiotics”
This is a review delineating the role of probiotics in lactose intolerance,
antibiotic-associated diarrhea, gastroenteritis, traveler’s
diarrhea, irritable bowel syndrome, inflammatory bowel disease,
and colon cancer. Full text available online at www.ajcn.org.
|
